JERECZEK, BARBARA ALICJA
 Distribuzione geografica
Continente #
EU - Europa 30.148
NA - Nord America 11.602
AS - Asia 10.356
SA - Sud America 1.132
AF - Africa 228
OC - Oceania 134
Continente sconosciuto - Info sul continente non disponibili 13
Totale 53.613
Nazione #
DE - Germania 16.185
US - Stati Uniti d'America 11.276
GB - Regno Unito 4.243
CN - Cina 3.657
IT - Italia 3.304
SG - Singapore 2.459
SE - Svezia 1.502
HK - Hong Kong 1.327
RU - Federazione Russa 1.139
BR - Brasile 875
FR - Francia 760
IN - India 727
IE - Irlanda 719
NL - Olanda 630
TR - Turchia 536
KR - Corea 417
FI - Finlandia 380
UA - Ucraina 349
ID - Indonesia 303
VN - Vietnam 268
CA - Canada 234
EU - Europa 183
DK - Danimarca 174
JP - Giappone 164
ES - Italia 140
PL - Polonia 125
AU - Australia 120
AT - Austria 103
PH - Filippine 94
MA - Marocco 87
BE - Belgio 75
CO - Colombia 75
CH - Svizzera 72
AR - Argentina 58
GR - Grecia 45
BD - Bangladesh 44
MX - Messico 44
PT - Portogallo 44
TW - Taiwan 43
IQ - Iraq 38
ZA - Sudafrica 36
PK - Pakistan 35
CL - Cile 34
EC - Ecuador 32
CZ - Repubblica Ceca 29
IR - Iran 28
EG - Egitto 26
VE - Venezuela 26
RO - Romania 23
SA - Arabia Saudita 22
TN - Tunisia 21
NO - Norvegia 20
IL - Israele 19
TH - Thailandia 19
MY - Malesia 18
NG - Nigeria 18
PE - Perù 17
AE - Emirati Arabi Uniti 16
HU - Ungheria 16
UZ - Uzbekistan 16
CR - Costa Rica 15
JO - Giordania 15
NP - Nepal 15
NZ - Nuova Zelanda 14
AZ - Azerbaigian 13
KE - Kenya 13
KG - Kirghizistan 10
KZ - Kazakistan 9
AL - Albania 8
SK - Slovacchia (Repubblica Slovacca) 8
PA - Panama 7
RS - Serbia 7
BG - Bulgaria 6
DO - Repubblica Dominicana 6
GE - Georgia 6
IS - Islanda 6
KW - Kuwait 6
LK - Sri Lanka 6
SC - Seychelles 6
BO - Bolivia 5
EE - Estonia 5
HN - Honduras 5
LT - Lituania 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
BY - Bielorussia 4
ET - Etiopia 4
HR - Croazia 4
JM - Giamaica 4
MN - Mongolia 4
OM - Oman 4
SI - Slovenia 4
SY - Repubblica araba siriana 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
AO - Angola 3
LU - Lussemburgo 3
PY - Paraguay 3
AD - Andorra 2
BA - Bosnia-Erzegovina 2
Totale 53.746
Città #
Frankfurt am Main 14.972
Southend 3.797
Singapore 1.563
Chandler 1.323
Hong Kong 1.190
Milan 1.145
Princeton 815
Seattle 738
Dublin 698
Beijing 609
Wilmington 607
Ashburn 592
Council Bluffs 577
Fairfield 411
Bengaluru 325
Santa Clara 308
Nanjing 267
Des Moines 254
Redmond 242
Dearborn 238
Houston 238
Jakarta 225
Woodbridge 215
Cambridge 211
Mountain View 198
Jacksonville 197
Munich 195
Ann Arbor 166
Toronto 165
Cangzhou 162
Phoenix 162
Shanghai 157
Rome 156
Columbus 155
Jinan 152
Sakarya 148
Los Angeles 136
Redwood City 134
New York 131
Boardman 121
Helsinki 117
Berlin 110
Shenyang 109
Nuremberg 102
Hyderabad 100
The Dalles 91
Grafing 90
São Paulo 86
Dong Ket 77
Guangzhou 77
Istanbul 77
Nanchang 77
Florence 66
Tianjin 66
Andover 65
Changsha 64
Tokyo 63
Bogotá 61
Brussels 59
Eitensheim 59
Seoul 59
Hebei 58
Hangzhou 57
Medford 57
San Diego 56
Warsaw 55
Turin 53
Vienna 50
London 49
Paris 49
Central District 46
Fuzhou 44
Casablanca 43
Silver Spring 43
Serra 42
Turku 42
Athens 39
Düsseldorf 39
Haikou 39
Jiaxing 38
Madrid 38
Cinisello Balsamo 37
Pavia 36
Yubileyny 36
Boston 35
Chicago 34
Hanoi 34
Somerville 34
Sydney 34
Mumbai 33
Roxbury 32
Chengdu 31
Barcelona 30
San Francisco 30
Zhengzhou 30
Washington 29
Bühl 28
Ho Chi Minh City 28
Naples 28
Verona 28
Totale 37.314
Nome #
Salvage stereotactic body radiotherapy for local prostate cancer recurrence after radiotherapy: a retrospective multicentre study of the GETUG 1.037
A novel nomogram to identify candidates for active surveillance among patients with ISUP Grade Group 1 or ISUP Grade Group 2 prostate cancer, according to multiparametric magnetic resonance imaging findings 392
Treatment of muscle-invasive bladder cancer in patients without comorbidities and fit for surgery: Trimodality therapy vs radical cystectomy. Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 316
Evaluation of target coverage and margins adequacy during CyberKnife Lung Optimized Treatment 312
Radioablation +/- hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): Potential of imaging and biology (AIRC IG-22159) 306
Low PI-RADS assessment category excludes extraprostatic extension (≥pT3a) of prostate cancer : a histology-validated study including 301 operated patients 302
Association of quantitative mri-based radiomic features with prognostic factors and recurrence rate in oropharyngeal squamous cell carcinoma 294
Linee guida carcinoma della prostata : AIRO, 2016 271
No increase in toxicity of pelvic irradiation when intensity modulation is employed: clinical and dosimetric data of 208 patients treated with post-prostatectomy radiotherapy 251
Repeated MRIs during Active Surveillance: natural history of prostatic lesions and upgrading rates 251
M. D. Anderson symptom inventory head neck (MDASI-HN) questionnaire: Italian language psychometric validation in head and neck cancer patients treated with radiotherapy ± systemic therapy – A study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 251
Adjuvant radiotherapy treatment for soft tissue sarcoma of extremities and trunk. A retrospective mono-institutional analysis 249
Whole-body magnetic resonance imaging (WB-MRI) reporting with the METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P) : inter-observer agreement between readers of different expertise levels 245
STRA-MI-VT (STereotactic RadioAblation by Multimodal Imaging for Ventricular Tachycardia) : rationale and design of an Italian experimental prospective study 243
Machine Learning-Based Models for Prediction of Toxicity Outcomes in Radiotherapy 239
Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT) 237
Whole-body magnetic resonance imaging: Technique, guidelines and key applications 237
Cisplatin, etoposide and continuous infusion bleomycin in patients with testicular germ cell tumors: efficacy and toxicity data from a retrospective study 234
[11C]Choline PET/CT impacts treatment decision making in patients with prostate cancer referred for radiotherapy 234
Salvage image-guided intensity modulated or stereotactic body reirradiation of local recurrence of prostate cancer 222
Tossicità con radioterapia e brachiterapia 220
MR imaging for selection of patients for partial breast irradiation : a systematic review and meta-analysis 218
Perfusion CT is a valuable diagnostic method for prostate cancer: a prospective study of 94 patients 207
Bladder preservation in non-metastatic muscle-invasive bladder cancer (MIBC): a single-institution experience 203
Head and neck cancer radiotherapy amid COVID‐19 pandemic : Report from Milan, Italy 203
Clinical risk analysis of the patient’s path in an Advanced Radiotherapy Center (A.R.C.) through F.M.E.A. method 201
OLIGO-AIRO: a national survey on the role of radiation oncologist in the management of OLIGO-metastatic patients on the behalf of AIRO 201
Effects of sex and age on fat fraction, diffusion-weighted image signal intensity and apparent diffusion coefficient in the bone marrow of asymptomatic individuals: A cross-sectional whole-body mri study 201
Low Dose Rate Brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy : Practice and outcome analysis in a series of 2237 patients from 11 Institutions 198
Value of perfusion CT parameters, microvessl density and VEGF expression in differentiation of benign and malignant prostate tumours 197
Phase II prospective trial “Give Me Five” short-term high precision radiotherapy for early prostate cancer with simultaneous boost to the dominant intraprostatic lesion : the impact of toxicity on quality of life (AIRC IG-13218) 197
"Give me five" ultra-hypofractionated radiotherapy for localized prostate cancer: non-invasive ablative approach 196
Ductal carcinoma in situ and intraoperative partial breast irradiation: Who are the best candidates? Long-term outcome of a single institution series 195
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 192
Robot-assisted radical prostatectomy : multiparametric MR imaging-directed intraoperative frozen-section analysis to reduce the rate of positive surgical margins 191
The QUBIC instrument for CMB polarization measurements 190
Adjuvant and salvage radiation therapy after prostatectomy : investigating beliefs and practices of radiation oncologists 190
Oncoplastic Breast-Conserving Surgery for Synchronous Multicentric and Multifocal Tumors: Is It Oncologically Safe? A Retrospective Matched-Cohort Analysis 189
CyberKnife Ultra-Hypofractionated SBRT for Localized Prostate Cancer with Dose Escalation to the Dominant Intraprostatic Lesion: In Silico Planning Study 187
Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors 186
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 186
Recent advances in radiation oncology 185
High-performance prediction models for prostate cancer radiomics 184
COVID-19 outbreak and cancer radiotherapy disruption in Italy : Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 184
Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300 184
Correction: Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up (Prostate Cancer and Prostatic Diseases, (2020), 23, 1, (94-101), 10.1038/s41391-019-0160-3) 183
MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218) 183
Voxel-based analysis unveils regional dose differences associated with radiation-induced morbidity in head and neck cancer patients 181
Dosimetric Impact of Inter-Fraction Anatomical Changes in Carbon Ion Boost Treatment for High-Risk Prostate Cancer (AIRC IG 14300) 181
Model-supported radiotherapy personalization : in silico test of hyper- and hypo-fractionation effects 178
Management of patients with cardiac implantable electronic devices (CIED) undergoing radiotherapy : a consensus document from Associazione Italiana Aritmologia e Cardiostimolazione (AIAC), Associazione Italiana Radioterapia Oncologica (AIRO), Associazione Italiana Fisica Medica (AIFM) 177
Therapeutic Sequences in the Treatment of High-Risk Prostate Cancer: Paving the Way Towards Multimodal Tailored Approaches 177
Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up 176
Comparing TomoHelical and TomoDirect in postmastectomy hypofractionated radiotherapy after immediate breast reconstruction 175
Mixup (Sample Pairing) Can Improve the Performance of Deep Segmentation Networks 175
PROACTA: a survey on the actual attitude of the Italian radiation oncologists in the management and prescription of hormonal therapy in prostate cancer patients 174
Beyond D'Amico risk classes for predicting recurrence after external beam radiotherapy for prostate cancer: the Candiolo classifier 173
Correlation between CT perfusion and clinico-pathological features in prostate cancer: a prospective study 172
A global Unified Dosimetry Index (gUDI) to evaluate simultaneous integrated boost radiotherapy plans in prostate cancer 172
Acute toxicity of image-guided hypofractionated radiotherapy for prostate cancer: nonrandomized comparison with conventional fractionation 171
Urinary bladder preservation for muscle-invasive bladder cancer: a survey among radiation oncologists of Lombardy, Italy 171
CyberKnife®; Imaging-dose evaluation during IGRT-SRSand IGRT-SBRT treatments 171
The PROCAINA (Prostate Cancer Indication Attitudes) Project (Part I): A survey among Italian radiation oncologists on post-operative radiotherapy in prostate cancer 168
Oligorecurrent Prostate Cancer and Stereotactic Body Radiotherapy: Where Are We Now? A Systematic Review and Meta-analysis of Prospective Studies 168
Cytoreductive prostate radiotherapy in oligometastatic prostate cancer: A single centre analysis of toxicity and clinical outcome 167
Acute radiation dermatitis in breast cancer : topical therapy with vitamin E acetate in lipophilic gel 166
Intra- and inter-observer variability in breast tumour bed contouring and the controversial role of surgical clips 163
Intraoperative radiotherapy during radical prostatectomy for intermediate-risk to locally advanced prostate cancer: treatment technique and evaluation of perioperative and functional outcome vs standard radical prostatectomy, in a matched-pair analysis 162
A qualitative investigation on patient empowerment in prostate cancer 162
VERO (R) radiotherapy for low burden cancer: 789 patients with 957 lesions 162
Late toxicity of image-guided hypofractionated radiotherapy for prostate : non-randomized comparison with conventional fractionation 161
Machine Learning for Head and Neck Cancer: A Safe Bet?—A Clinically Oriented Systematic Review for the Radiation Oncologist 161
Stereotactic body radiotherapy for castration-sensitive prostate cancer bone oligometastases 160
Dose escalation for prostate cancer using the three-dimensional conformal dynamic arc technique : analysis of 542 consecutive patients 159
Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients 159
Artificial Intelligence for Medicine : An Applied Reference for Methods and Applications 159
Salvage therapy of intraprostatic failure after radical external-beam radiotherapy for prostate cancer : a review 158
Adjuvant radiotherapy in node positive prostate cancer patients: a debate still on. when, for whom? 158
Radiotherapy in prostate cancer patients with pelvic lymphocele after surgery: clinical and dosimetric data of 30 patients 157
Adaptive mathematical model of tumor response to radiotherapy based on CBCT data 157
Short-term high precision radiotherapy for early prostate cancer with concomitant boost to the dominant lesion : ad interim analysis and preliminary results of Phase II trial AIRC-IG-13218 157
Influence of different urinary bladder filling levels and controlling regions of interest selection on deformable image registration algorithms 157
High-dose-rate Brachytherapy as Adjuvant Local rEirradiation for Salvage Treatment of Recurrent breAst cancer (BALESTRA): a retrospective mono-institutional study 157
Clinical evaluation and disease management of PI-RADS 3 lesions. Analysis from a single tertiary high-volume center 157
Mammella. Radioterapia del carcinoma della mammella 156
Chemioterapia versus naprzemienna chemio-radioterapia u chorych z ograniczona postacia drobnokomórkowego raka pluca 155
Reporting combined outcomes with Trifecta and survival, continence, and potency (SCP) classification in 337 patients with prostate cancer treated with image-guided hypofractionated radiotherapy 155
Long-Term Results and Reconstruction Failure in Patients Receiving Postmastectomy Radiation Therapy with a Temporary Expander or Permanent Implant in Place 155
Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence : A Multi-institutional Analysis 154
20 Gy in five fractions versus 8 Gy in one fraction in palliative radiotherapy of bone metastases : a multicenter randomized study 151
COVID-19 and radiotherapy: impact on work and personal life of Lombardy residents during first lockdown, survey endorsed by AIRO Young 151
Predicting Pathological Features at Radical Prostatectomy in Patients with Prostate Cancer Eligible for Active Surveillance by Multiparametric Magnetic Resonance Imaging 150
Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy 149
Geometric contour variation in clinical target volume of axillary lymph nodes in breast cancer radiotherapy: an AIRO multi-institutional study 149
COMBINED SURGERY AND POST-OPERATIVE RADIOTHERAPY OR CHEMORADIOTHERAPY FOR LOCALLY ADVANCED TONGUE CANCER 148
Volumetric modulated arc therapy with rapidarc (RA-IMRT) for gunaecological malignancies 147
The role of MRI in the management of a prostate cancer patient with bone and lymph nodes metastases: A case report 146
Correlation between radiological and biological features and clinical outcomes in early prostate cancer: an exploratory subgroup analysis 146
The POLO (Partially Omitted Lobe) approach to safely treat in-breast recurrence after intraoperative radiotherapy with electrons 145
Domande dei lettori 144
Totale 19.934
Categoria #
all - tutte 153.223
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 153.223


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.660 286 217 178 194 293 401 208 193 562 189 602 337
2021/20224.110 167 139 135 163 258 301 266 269 379 447 377 1.209
2022/20236.043 741 571 511 639 511 1.088 223 401 647 119 400 192
2023/202414.288 193 308 335 255 956 523 2.251 1.992 986 1.920 2.269 2.300
2024/202515.738 2.158 2.230 1.758 1.566 813 511 363 1.149 667 1.008 1.188 2.327
2025/2026651 651 0 0 0 0 0 0 0 0 0 0 0
Totale 56.258